These Money Losses Won't Help You at Tax Time
How to Save and Invest for a House Down Payment
Are Grocery Store Customer Surveys Worth Your Time?
Netflix Isn't Going to Jack Up Your Rates Anytime Soon
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.